Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Sep 14;11(34):5322-6.
doi: 10.3748/wjg.v11.i34.5322.

Limited influences of chemotherapy on healthy and metastatic liver parenchyma

Affiliations

Limited influences of chemotherapy on healthy and metastatic liver parenchyma

Nancy Van Damme et al. World J Gastroenterol. .

Abstract

Aim: To examine the expression of E-cadherin, beta-catenin, gamma-catenin, VEGF, and p53 in 39 patients with hepatic metastasis from colorectal cancer immunohistochemically.

Methods: The patients were divided into two groups: those (n = 16) who had no chemotherapy for at least 6 mo before the liver resections and those (n = 23) who were treated with chemotherapy before liver resections. A score from 0 to 3 was given for the number of positive cells and from 0 to 3 for the intensity of staining in these cells, in both healthy and metastatic liver parenchyma.

Results: No significant differences in the expression of E-cadherin, beta- and gamma-catenin, VEGF and p53, could be observed between patients who received and did not receive chemotherapy, in both normal and metastatic liver parenchyma.

Conclusion: Despite the assumption that chemotherapy had an effect on liver metastasis, no influences were noticed immunohistochemically.

PubMed Disclaimer

Figures

Figure 1
Figure 1
E-cadherin expression in a liver metastasis. Magnification x40.
Figure 2
Figure 2
VEGF expression in a liver metastasis. Magnification x40.
Figure 3
Figure 3
p53 expression in a liver metastasis. Magnification x40.

Similar articles

Cited by

References

    1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin. 1999;49:8–31, 1. - PubMed
    1. Tournigand C, André T, Achille E, Lledo G, Flesh M, Mery-Mignard D, Quinaux E, Couteau C, Buyse M, Ganem G, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol. 2004;22:229–237. - PubMed
    1. Pignatelli M, Vessey CJ. Adhesion molecules: novel molecular tools in tumor pathology. Hum Pathol. 1994;25:849–856. - PubMed
    1. Kemler R. From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion. Trends Genet. 1993;9:317–321. - PubMed
    1. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science. 1991;251:1451–1455. - PubMed